Response to the Letter to the Editor from Christos Lazaridis, M.D. and Colleagues : Hypernatremia Predicts Adverse Cardiovascular Outcomes after SAH.

Response to the Letter to the Editor from Christos Lazaridis, M.D. and Colleagues : Hypernatremia Predicts Adverse Cardiovascular Outcomes after SAH. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Response to the Letter to the Editor from Christos Lazaridis, M.D. and Colleagues : Hypernatremia Predicts Adverse Cardiovascular Outcomes after SAH. Abstract Text:

Landis A Fisher,Nerissa Ko,Jacob Miss,Poyee P Tung,Alexander Kopelnik,Nader M Banki,David Gardner,Wade S Smith,Michael T Lawton,Jonathan G Zaroff,

Response to the Letter to the Editor from Christos Lazaridis, M.D. and Colleagues : Hypernatremia Predicts Adverse Cardiovascular Outcomes after SAH. Publishing Authors By Initials

LA Fisher,N Ko,J Miss,PP Tung,A Kopelnik,NM Banki,D Gardner,WS Smith,MT Lawton,JG Zaroff,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Response to the Letter to the Editor from Christos Lazaridis, M.D. and Colleagues : Hypernatremia Predicts Adverse Cardiovascular Outcomes after SAH. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Neurocritical care

VOLUME: 7

Page Numbers: 272

Journal Abbreviation:

ISSN: 1541-6933

DAY: 16

MONTH: 11

YEAR: 2007

Response to the Letter to the Editor from Christos Lazaridis, M.D. and Colleagues : Hypernatremia Predicts Adverse Cardiovascular Outcomes after SAH. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 101156086

Response to the Letter to the Editor from Christos Lazaridis, M.D. and Colleagues : Hypernatremia Predicts Adverse Cardiovascular Outcomes after SAH. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Response to the Letter to the Editor from Christos Lazaridis, M.D. and Colleagues : Hypernatremia Predicts Adverse Cardiovascular Outcomes after SAH. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Response to the Letter to the Editor from Christos Lazaridis, M.D. and Colleagues : Hypernatremia Predicts Adverse Cardiovascular Outcomes after SAH.

AFFILIATION: Divison of Cardiology, UCSF Medical Center, San Francisco, CA, USA, Zaroff@medicine.ucsf.edu.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Neurocrit Care

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Response to the Letter to the Editor from Christos Lazaridis, MD and Colleagues : Hypernatremia Predicts Adverse Cardiovascular Outcomes after SAH Related Publications

• Cardiovascular predictors of in-patient mortality after subarachnoid hemorrhage.
• Comparing the convergent validity and clinical utility of the Behavior Assessment System for Children-Parent Rating Scales and Child Behavior Checklist in children with epilepsy.
• Hypernatremia predicts adverse cardiovascular and neurological outcomes after SAH.
• Plasma B-type natriuretic peptide levels are associated with early cardiac dysfunction after subarachnoid hemorrhage.
• Predictors of left ventricular regional wall motion abnormalities after subarachnoid hemorrhage.
• Predictors of neurocardiogenic injury after subarachnoid hemorrhage.
• Prevalence and implications of diastolic dysfunction after subarachnoid hemorrhage.
• Response to the Letter to the Editor from Christos Lazaridis, M.D. and Colleagues : Hypernatremia Predicts Adverse Cardiovascular Outcomes after SAH.